URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jane Liesveld

Concepts (582)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Leukemia, Myeloid, Acute
20
1988
177
4.440
Why?
Hematopoietic Stem Cells
19
1989
197
3.210
Why?
Bone Marrow Transplantation
18
1993
197
2.790
Why?
Stem Cell Transplantation
7
1993
110
2.390
Why?
Antigens, CD34
22
1989
53
2.260
Why?
Hematopoietic Stem Cell Transplantation
15
1998
131
2.240
Why?
Leukemia
12
1991
158
2.190
Why?
Antineoplastic Agents
13
1999
619
2.030
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
1993
55
1.930
Why?
Leukemia, Myeloid
9
1988
119
1.800
Why?
Antineoplastic Combined Chemotherapy Protocols
19
1993
429
1.790
Why?
Hematopoiesis
11
1986
129
1.620
Why?
Bone Marrow Cells
15
1989
221
1.590
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
10
1993
81
1.480
Why?
Myelodysplastic Syndromes
5
2001
131
1.340
Why?
Humans
111
1986
36274
1.230
Why?
Hematopoietic Stem Cell Mobilization
5
2000
14
1.220
Why?
Boronic Acids
4
2005
29
1.140
Why?
Pyrazines
4
2005
33
1.130
Why?
Apoptosis
9
1996
823
1.110
Why?
Lymphoma, Non-Hodgkin
8
1988
113
1.060
Why?
Heterocyclic Compounds
4
2004
15
1.020
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
1999
82
1.010
Why?
Transplantation, Homologous
14
1995
276
1.000
Why?
Adult
55
1988
11351
0.990
Why?
Hematopoietic Cell Growth Factors
7
1993
16
0.930
Why?
Stem Cells
5
1986
361
0.920
Why?
Middle Aged
47
1988
9837
0.910
Why?
Graft vs Host Disease
9
1999
90
0.900
Why?
Thrombocytopenia
3
1987
74
0.880
Why?
Antigens, CD
13
1991
244
0.880
Why?
Neoplastic Stem Cells
6
1994
40
0.860
Why?
Cytokines
9
1988
565
0.850
Why?
Hodgkin Disease
6
1993
155
0.850
Why?
Hydrazines
1
2012
12
0.850
Why?
Receptors, Thrombopoietin
1
2012
9
0.850
Why?
Leukemia, Promyelocytic, Acute
2
2006
32
0.840
Why?
Benzoates
1
2012
14
0.840
Why?
Cell Survival
5
1989
551
0.820
Why?
Pyrazoles
1
2012
57
0.820
Why?
Stromal Cells
4
1996
66
0.800
Why?
Granulocyte Colony-Stimulating Factor
6
1993
44
0.790
Why?
Protease Inhibitors
1
2011
40
0.790
Why?
Cell Adhesion
10
1988
261
0.770
Why?
Molecular Targeted Therapy
1
2010
17
0.750
Why?
Integrins
3
1993
48
0.740
Why?
Registries
2
2008
223
0.730
Why?
Female
54
1988
19838
0.730
Why?
Neoplasm Proteins
4
1994
173
0.720
Why?
Quinolones
3
2001
27
0.700
Why?
Transplantation, Autologous
13
1993
144
0.690
Why?
Cell Movement
4
2001
361
0.690
Why?
Aged
35
1988
7269
0.690
Why?
Transplantation Chimera
2
2005
26
0.680
Why?
Bone Marrow
12
1986
287
0.670
Why?
Cytarabine
8
1998
89
0.670
Why?
Tumor Cells, Cultured
12
1991
881
0.660
Why?
Transplantation Tolerance
1
2008
3
0.650
Why?
Chromosomes, Human, Y
1
2008
4
0.650
Why?
Graft vs Tumor Effect
1
2008
7
0.650
Why?
Male
51
1988
19675
0.640
Why?
Graft Rejection
2
2005
143
0.630
Why?
Pyrimidines
4
2007
64
0.610
Why?
Thrombocythemia, Essential
1
2007
6
0.600
Why?
Janus Kinase 2
1
2007
13
0.590
Why?
Peripheral Blood Stem Cell Transplantation
3
2002
20
0.580
Why?
Cell Communication
2
2000
139
0.570
Why?
Alkyl and Aryl Transferases
2
2001
12
0.560
Why?
Eosinophilia
3
1988
31
0.560
Why?
Treatment Outcome
16
1993
2615
0.550
Why?
Methylprednisolone
2
1999
43
0.540
Why?
Graft Survival
3
2000
148
0.530
Why?
Neoplasms
4
2002
739
0.520
Why?
Coculture Techniques
5
1996
90
0.510
Why?
Hydroxyquinolines
3
1993
9
0.510
Why?
Antiviral Agents
2
2002
175
0.500
Why?
Antibodies, Monoclonal, Murine-Derived
5
2009
114
0.490
Why?
Lymphoma
4
1993
162
0.490
Why?
Farnesyltranstransferase
4
2001
14
0.490
Why?
Colony-Forming Units Assay
7
1988
39
0.490
Why?
Combined Modality Therapy
13
1991
486
0.470
Why?
Imagery (Psychotherapy)
1
2003
3
0.470
Why?
Antigens, CD18
3
1991
23
0.470
Why?
Enzyme Inhibitors
2
2001
422
0.470
Why?
Prognosis
9
1993
1083
0.470
Why?
Music Therapy
1
2003
4
0.470
Why?
Relaxation Therapy
1
2003
16
0.470
Why?
Quercetin
1
2003
14
0.450
Why?
Cord Blood Stem Cell Transplantation
1
2003
5
0.450
Why?
Adolescent
19
1993
4766
0.450
Why?
Stem Cell Factor
5
1993
17
0.440
Why?
Endothelial Cells
1
2005
182
0.440
Why?
Piperazines
3
2007
74
0.440
Why?
Piperidines
1
2003
44
0.440
Why?
Mice, SCID
5
2003
172
0.440
Why?
Blood Donors
1
2003
27
0.440
Why?
Flavonoids
1
2003
67
0.430
Why?
Acute Disease
9
1996
586
0.430
Why?
Cell Separation
4
1994
231
0.430
Why?
Disease-Free Survival
11
1995
198
0.420
Why?
Time Factors
10
1991
3182
0.420
Why?
Mice, Inbred NOD
4
2003
38
0.420
Why?
Survival Analysis
11
1993
606
0.420
Why?
Valine
1
2002
32
0.410
Why?
Acyclovir
1
2002
42
0.410
Why?
Growth Substances
3
1996
102
0.410
Why?
Antibodies, Monoclonal
9
1986
711
0.410
Why?
Multiple Myeloma
3
2004
76
0.410
Why?
Herpes Simplex
1
2002
47
0.400
Why?
Cell Differentiation
7
1991
1093
0.400
Why?
Transforming Growth Factor beta
3
1993
412
0.400
Why?
Retrospective Studies
13
1991
2267
0.380
Why?
Macrophage Inflammatory Proteins
1
2000
25
0.370
Why?
Survival Rate
12
1991
618
0.370
Why?
Chemokines
1
2001
111
0.370
Why?
Stomatitis
2
1999
16
0.370
Why?
Cell Cycle
4
1994
254
0.360
Why?
Nifedipine
1
1999
31
0.350
Why?
Parenteral Nutrition
1
1999
23
0.350
Why?
Remission Induction
9
1996
161
0.350
Why?
Receptors, Fc
2
1988
70
0.350
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
78
0.350
Why?
Cell Line, Tumor
4
2005
575
0.350
Why?
Drug Resistance, Neoplasm
3
1996
56
0.340
Why?
Methotrexate
1
1999
73
0.340
Why?
Mouth Mucosa
1
1999
43
0.340
Why?
Tissue Preservation
1
1999
20
0.340
Why?
Neoplasm Recurrence, Local
3
2009
288
0.340
Why?
Child
12
1995
4155
0.340
Why?
Cyclosporine
1
1999
64
0.340
Why?
Lymphoma, Follicular
2
1991
54
0.340
Why?
Calcium Channel Blockers
1
1999
67
0.340
Why?
Immunosuppressive Agents
2
1999
200
0.340
Why?
Recurrence
10
1993
691
0.330
Why?
Immunotherapy
2
1994
86
0.320
Why?
Amifostine
2
2004
27
0.310
Why?
Parvoviridae Infections
2
1993
11
0.300
Why?
Child, Preschool
9
1997
2660
0.300
Why?
Nuclear Proteins
2
1994
335
0.300
Why?
Phenotype
4
1989
763
0.300
Why?
Cell Adhesion Molecules
2
1994
70
0.300
Why?
Interleukin-1
4
1988
218
0.300
Why?
Antilymphocyte Serum
3
2005
25
0.290
Why?
Vidarabine
2
2005
26
0.290
Why?
B-Lymphocytes
3
1990
432
0.290
Why?
Nitric Oxide
1
1999
250
0.280
Why?
Interleukin-3
4
1991
43
0.280
Why?
Leukemia, Megakaryoblastic, Acute
1
1996
10
0.280
Why?
Cells, Cultured
7
1989
2479
0.280
Why?
Drug Resistance, Multiple
1
1996
30
0.270
Why?
Etoposide
4
1998
83
0.270
Why?
ABO Blood-Group System
3
2003
66
0.270
Why?
Mice
9
1995
6111
0.270
Why?
Dendritic Cells
2
2002
121
0.270
Why?
Endothelium, Vascular
2
1994
406
0.270
Why?
Oxygen
1
1999
493
0.270
Why?
Neutrophils
1
1998
312
0.270
Why?
Tretinoin
1
2006
103
0.260
Why?
Platelet Transfusion
2
2005
85
0.260
Why?
Cell Proliferation
2
2007
515
0.260
Why?
Databases, Factual
2
1999
156
0.260
Why?
Follow-Up Studies
5
1997
1855
0.260
Why?
Carmustine
3
1998
37
0.250
Why?
Extracellular Matrix
3
1989
162
0.240
Why?
Flow Cytometry
7
1990
603
0.240
Why?
Tumor Necrosis Factor-alpha
5
1993
659
0.240
Why?
Animals
13
1992
16093
0.240
Why?
Cell Division
4
1996
762
0.240
Why?
Macrophages
2
1991
346
0.240
Why?
E-Selectin
2
1994
17
0.230
Why?
Gene Expression Regulation, Neoplastic
1
2006
256
0.230
Why?
Giant Cells
1
1993
11
0.230
Why?
Antigens, Differentiation
2
1989
68
0.230
Why?
Histiocytoma, Benign Fibrous
1
1993
23
0.230
Why?
Transplantation Conditioning
2
2010
33
0.230
Why?
Antigens, Neoplasm
1
1994
106
0.230
Why?
Dose-Response Relationship, Drug
7
2000
1117
0.230
Why?
AIDS-Related Complex
1
1993
14
0.220
Why?
Blast Crisis
3
2006
18
0.220
Why?
Parvovirus B19, Human
1
1993
5
0.220
Why?
Caspase 3
2
2003
88
0.220
Why?
Erythroid Precursor Cells
1
1993
10
0.220
Why?
Granulocytes
2
1989
80
0.220
Why?
Red-Cell Aplasia, Pure
1
1993
9
0.220
Why?
Receptors, CXCR4
2
2001
25
0.220
Why?
Hematologic Neoplasms
3
1999
35
0.220
Why?
Infant
6
1999
2278
0.220
Why?
Caspases
2
2003
101
0.220
Why?
Cytoprotection
2
2004
37
0.220
Why?
Erythropoiesis
2
1987
62
0.210
Why?
Platelet Count
1
2012
50
0.210
Why?
Glucocorticoids
2
1987
162
0.210
Why?
Colony-Stimulating Factors
2
1988
27
0.210
Why?
Antibodies
3
1993
212
0.210
Why?
Fatal Outcome
1
2012
104
0.200
Why?
Antibody-Dependent Cell Cytotoxicity
2
1986
28
0.200
Why?
Abnormal Karyotype
1
2011
1
0.200
Why?
Benzenesulfonates
1
2011
7
0.200
Why?
Arsenicals
1
2011
6
0.200
Why?
Azacitidine
1
2011
17
0.200
Why?
Oxides
1
2011
21
0.200
Why?
Chromosomes, Human, Pair 5
1
2011
8
0.200
Why?
Thalidomide
1
2011
12
0.200
Why?
Gastrointestinal Tract
1
2011
26
0.190
Why?
Lambert-Eaton Myasthenic Syndrome
1
1991
3
0.190
Why?
Adverse Drug Reaction Reporting Systems
1
2010
7
0.190
Why?
Antigens, CD11
2
1991
3
0.190
Why?
Case-Control Studies
2
2003
617
0.190
Why?
P-Selectin
2
2007
22
0.190
Why?
Chromosome Deletion
1
2011
61
0.190
Why?
Nitrogen Mustard Compounds
1
2011
20
0.190
Why?
Pyridines
1
2011
75
0.190
Why?
Sesquiterpenes
2
2007
24
0.190
Why?
Lymphoma, Mantle-Cell
1
2011
21
0.190
Why?
Cohort Studies
5
2001
969
0.180
Why?
Culture Media
2
1988
195
0.180
Why?
Recombinant Proteins
5
1988
723
0.180
Why?
Bone Marrow Diseases
2
1995
43
0.180
Why?
Kinetics
3
1991
1391
0.180
Why?
Melphalan
2
2004
28
0.170
Why?
Biomimetic Materials
1
2009
3
0.170
Why?
Toll-Like Receptor 9
1
2009
12
0.170
Why?
T-Lymphocyte Subsets
2
1994
112
0.170
Why?
Blood Component Removal
1
2009
11
0.170
Why?
Lymphocytosis
1
2009
14
0.170
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2009
16
0.170
Why?
Interleukin-7
3
1994
10
0.160
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1991
127
0.160
Why?
Analysis of Variance
3
1999
736
0.160
Why?
Blood Cell Count
3
1987
45
0.160
Why?
Erythrocyte Transfusion
2
2005
57
0.160
Why?
Genetic Diseases, Inborn
1
2008
17
0.160
Why?
Immunophenotyping
4
1993
114
0.160
Why?
Pilot Projects
3
2001
442
0.160
Why?
Skin Neoplasms
1
2011
229
0.160
Why?
Thiazoles
1
2009
90
0.160
Why?
Killer Cells, Natural
1
2009
121
0.160
Why?
T-Lymphocytes, Cytotoxic
1
2009
128
0.160
Why?
Pelger-Huet Anomaly
1
1988
1
0.160
Why?
Protein Kinase Inhibitors
1
2009
92
0.160
Why?
Hydrocortisone
1
1988
131
0.160
Why?
Biological Agents
1
1988
20
0.160
Why?
Soft Tissue Neoplasms
1
2008
46
0.160
Why?
Karyotyping
3
2006
109
0.150
Why?
Whole-Body Irradiation
4
1995
83
0.150
Why?
Thiadiazoles
1
2007
12
0.150
Why?
Sarcoma
1
2008
63
0.150
Why?
DNA Mutational Analysis
1
2008
189
0.150
Why?
Interleukin-2
1
1988
198
0.150
Why?
Translocation, Genetic
1
2007
63
0.150
Why?
Philadelphia Chromosome
1
2007
11
0.150
Why?
Chemokine CXCL12
1
2007
34
0.150
Why?
Anemia, Hemolytic, Autoimmune
1
1987
21
0.150
Why?
HIV-1
1
1993
536
0.150
Why?
Predictive Value of Tests
3
1993
606
0.140
Why?
Skin Diseases
1
2008
120
0.140
Why?
Reticulocytes
1
1987
45
0.140
Why?
Amnesia, Anterograde
1
2006
1
0.140
Why?
Cyclophosphamide
3
1998
174
0.140
Why?
Liver
1
2011
877
0.140
Why?
Central Nervous System Depressants
1
2006
10
0.140
Why?
Adjuvants, Immunologic
2
1993
117
0.140
Why?
Phosphorylation
2
2001
774
0.140
Why?
Neoplasms, Second Primary
1
2008
125
0.140
Why?
Point Mutation
1
2007
172
0.140
Why?
Obesity
1
2010
339
0.140
Why?
Fibroblasts
4
1986
534
0.130
Why?
Ethanol
1
2006
92
0.130
Why?
Plasma Cells
1
2005
20
0.130
Why?
Gene Expression Profiling
1
2008
301
0.130
Why?
Thalassemia
1
2005
23
0.130
Why?
Young Adult
4
2009
1059
0.130
Why?
Hispanic Americans
1
2005
93
0.120
Why?
Anemia, Sickle Cell
1
2005
47
0.120
Why?
Drug Therapy, Combination
2
1999
382
0.120
Why?
Calcium
2
2000
1083
0.120
Why?
Ethnic Groups
1
2005
152
0.120
Why?
Mutation
2
2001
1216
0.120
Why?
Radiotherapy, Adjuvant
2
1998
73
0.120
Why?
Enzyme Activation
2
2001
554
0.120
Why?
Hemorrhage
1
2005
180
0.120
Why?
Histocompatibility
1
2003
13
0.120
Why?
RNA, Messenger
3
1992
1863
0.120
Why?
Annexin A5
1
2003
18
0.110
Why?
Decision Support Techniques
1
2004
74
0.110
Why?
Poly(ADP-ribose) Polymerases
1
2003
58
0.110
Why?
Histocompatibility Testing
3
2005
37
0.110
Why?
Gene Expression Regulation, Leukemic
2
1997
19
0.110
Why?
Blood Group Incompatibility
1
2003
37
0.110
Why?
Cell Line
3
1988
1585
0.110
Why?
Transplantation Immunology
1
2003
18
0.110
Why?
Severity of Illness Index
3
1993
922
0.110
Why?
Feasibility Studies
1
2003
202
0.110
Why?
Vomiting
1
2003
115
0.110
Why?
Interferon-gamma
2
1999
348
0.110
Why?
Fetal Blood
1
2003
91
0.110
Why?
Cell Culture Techniques
1
2003
92
0.110
Why?
Leukocyte Count
2
1988
161
0.110
Why?
S Phase
2
1999
47
0.110
Why?
Cell Death
3
2005
172
0.100
Why?
Chronic Disease
3
1993
522
0.100
Why?
Pancytopenia
3
2001
13
0.100
Why?
Interleukins
2
1991
63
0.100
Why?
Nausea
1
2003
155
0.100
Why?
Pain Measurement
1
2003
246
0.100
Why?
Chemokines, CX3C
1
2001
8
0.100
Why?
Prospective Studies
3
1993
1689
0.100
Why?
Injections, Intravenous
1
2002
131
0.100
Why?
Leukopenia
2
1987
24
0.100
Why?
Chemokines, CC
1
2001
30
0.100
Why?
Chemokines, CXC
1
2001
45
0.100
Why?
Administration, Oral
1
2002
308
0.100
Why?
Syndrome
2
1991
208
0.100
Why?
Sweat Gland Diseases
1
2000
2
0.090
Why?
Interleukin-8
1
2001
111
0.090
Why?
T-Lymphocytes
3
1991
550
0.090
Why?
Chemokine CCL4
1
2000
23
0.090
Why?
Blood Grouping and Crossmatching
3
2000
32
0.090
Why?
Chemokine CCL3
1
2000
20
0.090
Why?
Oxidative Stress
2
1999
346
0.090
Why?
Salvage Therapy
2
2009
59
0.090
Why?
Regression Analysis
1
2002
527
0.090
Why?
Pentoxifylline
1
2000
26
0.090
Why?
Lymphocyte Activation
2
1997
410
0.090
Why?
Pain
1
2003
382
0.090
Why?
Tissue Donors
3
2000
69
0.090
Why?
Anemia, Aplastic
1
1999
25
0.090
Why?
HLA Antigens
3
2000
99
0.090
Why?
Wiskott-Aldrich Syndrome
1
1999
9
0.090
Why?
Kaplan-Meier Estimate
2
2010
222
0.090
Why?
Life Tables
1
1999
39
0.090
Why?
Diarrhea
1
1999
66
0.090
Why?
Penicillamine
1
1999
25
0.080
Why?
Partial Pressure
1
1999
52
0.080
Why?
Receptor Protein-Tyrosine Kinases
2
1995
74
0.080
Why?
Nitrites
1
1999
34
0.080
Why?
Corynebacterium Infections
1
1998
8
0.080
Why?
Proto-Oncogene Proteins c-kit
2
1995
15
0.080
Why?
Infectious Mononucleosis
1
1998
21
0.080
Why?
Nitric Oxide Synthase Type II
1
1999
57
0.080
Why?
Enzyme Induction
1
1999
153
0.080
Why?
Polymerase Chain Reaction
2
1993
596
0.080
Why?
Lysine
1
1999
73
0.080
Why?
Cause of Death
1
1999
162
0.080
Why?
HL-60 Cells
2
2007
52
0.080
Why?
Leukocyte Rolling
2
2007
16
0.080
Why?
Chemotaxis
1
1998
32
0.080
Why?
Neutropenia
1
1999
67
0.080
Why?
Nitric Oxide Synthase
1
1999
166
0.080
Why?
Receptors, Erythropoietin
1
1997
6
0.080
Why?
Patient Selection
1
1999
212
0.080
Why?
Leukocytes, Mononuclear
2
2007
110
0.080
Why?
Phagocytosis
1
1998
85
0.080
Why?
Aged, 80 and over
3
2006
2529
0.080
Why?
Monocytes
2
1988
308
0.080
Why?
Lipopolysaccharides
1
1999
211
0.080
Why?
Globins
1
1997
49
0.070
Why?
Proto-Oncogene Proteins
2
1995
289
0.070
Why?
Yolk Sac
1
1997
57
0.070
Why?
Receptors, Interleukin
1
1997
10
0.070
Why?
L-Selectin
1
1997
15
0.070
Why?
Reference Values
2
1991
439
0.070
Why?
Actins
1
1998
192
0.070
Why?
Connective Tissue
1
1997
43
0.070
Why?
Reactive Oxygen Species
1
1999
301
0.070
Why?
Proteoglycans
1
1997
100
0.070
Why?
Bucladesine
1
1996
44
0.070
Why?
Embryo, Mammalian
1
1997
188
0.070
Why?
B-Lymphocyte Subsets
1
1997
57
0.070
Why?
RNA
1
2000
397
0.070
Why?
Extracellular Matrix Proteins
1
1997
74
0.070
Why?
Myeloablative Agonists
2
2000
6
0.070
Why?
Erythropoietin
1
1996
28
0.070
Why?
DNA, Neoplasm
1
1996
128
0.070
Why?
Microscopy, Electron
1
1996
377
0.070
Why?
Receptors, Colony-Stimulating Factor
1
1995
1
0.060
Why?
Drug Administration Schedule
2
2003
366
0.060
Why?
Actuarial Analysis
2
1991
21
0.060
Why?
Chromosome Aberrations
2
2003
115
0.060
Why?
Vascular Cell Adhesion Molecule-1
1
1994
41
0.060
Why?
Umbilical Veins
1
1994
76
0.060
Why?
Leukemia, Experimental
1
1994
20
0.060
Why?
Ki-67 Antigen
1
1994
29
0.060
Why?
Gene Expression Regulation
1
2000
888
0.060
Why?
Treatment Failure
2
2001
128
0.060
Why?
In Situ Hybridization, Fluorescence
2
2002
110
0.060
Why?
Anemia
1
1994
78
0.060
Why?
Interleukin-4
2
1991
163
0.060
Why?
Rabbits
2
2005
697
0.060
Why?
Macrophage Colony-Stimulating Factor
1
1993
24
0.060
Why?
Neoplasm Invasiveness
1
1994
155
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2000
92
0.060
Why?
Intercellular Adhesion Molecule-1
1
1994
125
0.060
Why?
Recombinant Fusion Proteins
2
2002
382
0.060
Why?
Leukemia, Monocytic, Acute
1
1993
12
0.060
Why?
Lymphocytes
1
1994
291
0.060
Why?
Tetradecanoylphorbol Acetate
1
1993
149
0.060
Why?
Clinical Trials as Topic
1
1997
671
0.060
Why?
Platelet-Derived Growth Factor
1
1993
108
0.050
Why?
Immunoglobulins, Intravenous
1
1993
36
0.050
Why?
Up-Regulation
1
1994
363
0.050
Why?
Infection
2
2000
66
0.050
Why?
Dexamethasone
1
1993
181
0.050
Why?
Megakaryocytes
1
1993
67
0.050
Why?
Risk Factors
3
2003
2345
0.050
Why?
Sea Urchins
1
1992
16
0.050
Why?
Aniline Compounds
1
1992
24
0.050
Why?
Dogs
2
1995
468
0.050
Why?
Cell Count
2
2002
286
0.050
Why?
Injections, Intra-Arterial
1
2011
31
0.050
Why?
Leukemia, Myelomonocytic, Chronic
2
2001
19
0.050
Why?
Ribosomal Proteins
1
1992
42
0.050
Why?
RNA, Ribosomal
1
1992
68
0.050
Why?
Cytotoxicity Tests, Immunologic
1
1991
31
0.050
Why?
Disease Outbreaks
1
1992
117
0.050
Why?
Maximum Tolerated Dose
1
2010
17
0.050
Why?
Mucositis
1
2010
13
0.050
Why?
Medical Records
1
2011
124
0.050
Why?
Drug Resistance
1
2011
102
0.050
Why?
Neutralization Tests
1
1991
129
0.050
Why?
Plastics
1
1990
13
0.050
Why?
Proportional Hazards Models
2
1993
450
0.050
Why?
Cell Transformation, Neoplastic
1
2011
137
0.050
Why?
Thinness
1
2010
11
0.050
Why?
Nuclear Family
2
2000
13
0.050
Why?
Electrophysiology
1
1991
247
0.050
Why?
Overweight
1
2010
38
0.050
Why?
Antigens, Differentiation, B-Lymphocyte
1
1990
51
0.050
Why?
Gene Expression
1
1993
751
0.040
Why?
Vincristine
1
2009
62
0.040
Why?
Chemokine CXCL10
1
2009
24
0.040
Why?
Immobilized Proteins
1
2009
1
0.040
Why?
Chi-Square Distribution
1
1991
344
0.040
Why?
Pleurisy
1
2009
1
0.040
Why?
Clinical Trials, Phase II as Topic
1
2009
13
0.040
Why?
Cell Compartmentation
1
1989
55
0.040
Why?
Atrial Fibrillation
1
2010
110
0.040
Why?
Lymphoma, B-Cell, Marginal Zone
1
2009
11
0.040
Why?
Colitis
1
2009
24
0.040
Why?
Doxorubicin
1
2009
107
0.040
Why?
Lymphoproliferative Disorders
1
2009
30
0.040
Why?
Fibronectins
1
1990
146
0.040
Why?
Prednisone
1
2009
165
0.040
Why?
Oligodeoxyribonucleotides
1
2009
136
0.040
Why?
Eosinophils
1
1988
49
0.040
Why?
Surface Properties
1
2009
165
0.040
Why?
HIV Infections
1
1994
579
0.040
Why?
Cladribine
1
2008
6
0.040
Why?
Multicenter Studies as Topic
1
2009
129
0.040
Why?
Biopsy, Fine-Needle
1
2008
21
0.040
Why?
Triterpenes
1
2008
1
0.040
Why?
Binding Sites, Antibody
1
1988
32
0.040
Why?
Diagnosis, Differential
1
2011
874
0.040
Why?
Neoadjuvant Therapy
1
2008
32
0.040
Why?
Data Interpretation, Statistical
1
2009
157
0.040
Why?
Terpenes
1
2008
16
0.040
Why?
Comorbidity
1
2010
380
0.040
Why?
Deoxycytidine
1
2008
28
0.040
Why?
Cysteine Proteinase Inhibitors
1
2008
28
0.040
Why?
Chemokine CCL2
1
2009
127
0.040
Why?
Chemotherapy, Adjuvant
1
2008
88
0.040
Why?
Neoplasm Metastasis
1
2009
228
0.040
Why?
Cycloheximide
1
1988
86
0.040
Why?
Chromosomes, Human, Pair 8
1
2007
14
0.040
Why?
Aldehydes
1
2008
27
0.040
Why?
Chromosomes, Human, Pair 21
1
2007
12
0.040
Why?
Databases, Genetic
1
2008
26
0.040
Why?
Xenograft Model Antitumor Assays
1
2008
47
0.040
Why?
Proteasome Endopeptidase Complex
1
2008
70
0.040
Why?
Siblings
1
2007
36
0.040
Why?
fms-Like Tyrosine Kinase 3
1
2007
4
0.040
Why?
Antigens, Human Platelet
1
2007
8
0.040
Why?
Saccharomyces cerevisiae Proteins
1
1992
268
0.040
Why?
Receptors, IgG
1
1988
68
0.040
Why?
Leukocyte Reduction Procedures
1
2007
11
0.040
Why?
Physician's Practice Patterns
1
1991
243
0.040
Why?
Biological Availability
1
2007
40
0.040
Why?
Exons
1
2008
168
0.040
Why?
Culture Media, Conditioned
1
2007
62
0.040
Why?
Drug Design
1
2007
42
0.040
Why?
Models, Genetic
1
2008
161
0.040
Why?
Thrombocytosis
1
1987
5
0.040
Why?
Chromosome Banding
1
2007
29
0.040
Why?
Centromere
1
2007
11
0.040
Why?
Sulfhydryl Compounds
1
2007
71
0.040
Why?
Leukocytosis
1
1987
21
0.040
Why?
HSP40 Heat-Shock Proteins
1
2006
6
0.040
Why?
Hematocrit
1
1987
112
0.040
Why?
Tumor Markers, Biological
1
2009
229
0.040
Why?
Endothelium
1
1986
57
0.040
Why?
Structure-Activity Relationship
1
2007
309
0.040
Why?
Drinking Behavior
1
2006
9
0.040
Why?
Forensic Medicine
1
2006
8
0.040
Why?
Data Collection
1
2007
215
0.040
Why?
Tumor Suppressor Protein p53
1
2007
138
0.030
Why?
Proteins
1
2009
468
0.030
Why?
DNA Nucleotidylexotransferase
2
1994
14
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2008
286
0.030
Why?
Postoperative Complications
1
2010
733
0.030
Why?
Antibodies, Neoplasm
1
2005
39
0.030
Why?
Immunohistochemistry
1
2009
1064
0.030
Why?
Risk
1
2006
368
0.030
Why?
Protein Kinase C
1
2007
232
0.030
Why?
Immunoglobulin Fab Fragments
1
2005
31
0.030
Why?
Minority Groups
1
2005
56
0.030
Why?
Immunoglobulin G
1
2007
488
0.030
Why?
Hemoglobinopathies
1
2005
6
0.030
Why?
Cell Membrane
1
2007
482
0.030
Why?
Drug Synergism
1
2005
159
0.030
Why?
Reproducibility of Results
1
2008
877
0.030
Why?
Sensitivity and Specificity
1
2008
905
0.030
Why?
Radiation-Protective Agents
1
2004
41
0.030
Why?
Gene Expression Regulation, Developmental
2
1997
351
0.030
Why?
Markov Chains
1
2004
40
0.030
Why?
Tomography, X-Ray Computed
1
2008
759
0.030
Why?
Cytogenetics
1
2003
14
0.030
Why?
Logistic Models
1
2006
611
0.030
Why?
Blood Transfusion
1
2005
171
0.030
Why?
NF-kappa B
1
2007
432
0.030
Why?
Statistics, Nonparametric
1
2004
262
0.030
Why?
Microscopy, Phase-Contrast
1
2002
16
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2002
11
0.030
Why?
Odds Ratio
1
2003
315
0.030
Why?
Protein Prenylation
1
2001
4
0.020
Why?
Genes, ras
1
2001
34
0.020
Why?
Mitoxantrone
1
2001
20
0.020
Why?
Anemia, Refractory, with Excess of Blasts
1
2001
9
0.020
Why?
Questionnaires
1
2006
1004
0.020
Why?
Hyperbilirubinemia
1
2001
11
0.020
Why?
Disease Progression
1
2003
521
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2001
91
0.020
Why?
Drug-Induced Liver Injury
1
2001
36
0.020
Why?
Randomized Controlled Trials as Topic
1
2003
411
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2001
92
0.020
Why?
Graft vs Leukemia Effect
1
2000
8
0.020
Why?
Necrosis
1
2000
103
0.020
Why?
Infant, Newborn
1
2005
1844
0.020
Why?
Drug Toxicity
1
2000
16
0.020
Why?
Drug Evaluation
1
2000
101
0.020
Why?
Evaluation Studies as Topic
1
2000
245
0.020
Why?
Mitogen-Activated Protein Kinases
1
2001
191
0.020
Why?
Placebos
1
2000
178
0.020
Why?
DNA Replication
1
2001
200
0.020
Why?
Bone Marrow Examination
1
1998
23
0.020
Why?
Behavior Therapy
1
2000
98
0.020
Why?
Base Sequence
2
1992
1683
0.020
Why?
Signal Transduction
1
2007
1567
0.020
Why?
Molecular Sequence Data
2
1992
1988
0.020
Why?
Mice, Inbred ICR
1
1997
86
0.020
Why?
Oligonucleotides, Antisense
1
1997
52
0.020
Why?
Organ Culture Techniques
1
1997
98
0.020
Why?
Erythroblasts
1
1997
39
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
United States
1
2005
2688
0.020
Why?
Embryonic and Fetal Development
1
1997
96
0.020
Why?
Receptors, Interleukin-7
1
1997
4
0.020
Why?
Antigens, CD19
1
1997
10
0.020
Why?
Antigens, CD45
1
1997
37
0.020
Why?
Double-Blind Method
1
2000
992
0.020
Why?
Clone Cells
1
1997
186
0.020
Why?
Multivariate Analysis
1
1997
541
0.020
Why?
Immunomagnetic Separation
1
1994
7
0.020
Why?
Radiation Dosage
1
1995
125
0.020
Why?
Growth Inhibitors
1
1994
38
0.020
Why?
Radiation Tolerance
1
1995
89
0.020
Why?
Autoantibodies
1
1994
98
0.020
Why?
Chromatography, Affinity
1
1994
88
0.020
Why?
HIV
1
1994
71
0.020
Why?
Radiotherapy
1
1995
198
0.010
Why?
Ectoderm
1
1992
13
0.010
Why?
Endoderm
1
1992
11
0.010
Why?
RNA Probes
1
1992
23
0.010
Why?
Oogenesis
1
1992
8
0.010
Why?
Larva
1
1992
44
0.010
Why?
Embryo, Nonmammalian
1
1992
46
0.010
Why?
Nucleic Acid Hybridization
1
1992
175
0.010
Why?
Age Factors
1
1995
1128
0.010
Why?
Cytoplasm
1
1992
197
0.010
Why?
Models, Biological
1
1994
1008
0.010
Why?
Amino Acid Sequence
1
1992
1195
0.010
Why?
Transcription, Genetic
1
1992
812
0.010
Why?
Saccharomyces cerevisiae
1
1992
386
0.010
Why?

Visualizations


Liesveld's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department